Johnson & Johnson

NYSE: JNJ · Real-Time Price · USD
177.75
1.50 (0.85%)
At close: Aug 19, 2025, 3:59 PM
178.64
0.50%
After-hours: Aug 19, 2025, 07:59 PM EDT

Johnson & Johnson Income Statement

Financials in USD. Fiscal year is February - January.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 29, 2024 Dec 31, 2023 Jan 1, 2023 Jan 2, 2022
Revenue
88.82B 85.16B 79.99B 78.74B
Cost of Revenue
27.47B 26.55B 24.6B 23.4B
Gross Profit
61.35B 58.61B 55.39B 55.34B
Operating Income
22.15B 23.41B 21.01B 20.94B
Interest Income
1.33B 1.26B 490M 53M
Pretax Income
16.69B 15.06B 19.36B 19.18B
Net Income
14.07B 35.15B 17.94B 20.88B
Selling & General & Admin
21.97B 20.11B 20.25B 20.12B
Research & Development
17.23B 15.09B 14.13B 14.28B
Other Expenses
n/a n/a n/a n/a
Operating Expenses
39.2B 35.2B 34.38B 34.4B
Interest Expense
755M 772M 276M 183M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
66.67B 61.75B 58.98B 57.8B
Income Tax Expense
2.62B 1.74B 2.99B 1.38B
Shares Outstanding (Basic)
2.41B 2.53B 2.61B 2.63B
Shares Outstanding (Diluted)
2.43B 2.56B 2.66B 2.67B
EPS (Basic)
5.84 13.88 6.83 7.93
EPS (Diluted)
5.79 13.72 6.73 7.81
EBITDA
24.78B 23.32B 26.61B 26.75B
EBIT
17.44B 15.83B 19.64B 19.36B
Depreciation & Amortization
7.34B 7.49B 6.97B 7.39B